Table 1.

Patient characteristics.

Patients, n	11
Female, n (%)	5 (45.5%)
Male, n (%)	6 (54.5%)
Age (years), median (range)	66 (47–86)
Karnofsky performance score, n (%)
100%	1 (9.1%)
90%	6 (54.5%)
80%	3 (27.3%)
60%	1 (9.1%)
Histology of treated lesions, n (%)
Cholangiocarcinoma	2 (13.3%)
Metastasis neuroendocrine tumor	6 (40.0%)
Metastasis colorectal adenocarcinoma	4 (26.6%)
Metastasis sarcoma	2 (13.3%)
Metastasis gastrointestinal stroma tumor	1 (6.6%)
Pretreatments, n (%)
Surgery	4 (36.4%)
Brachytherapy	3 (27.3%)
SIRT	1 (9.1%)
No pretreatment	4 (36.4%)